Cholesterol-lowering Effects of Plant Stanol Ester
Primary Purpose
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Plant stanol ester
placebo
Sponsored by
About this trial
This is an interventional treatment trial for Dyslipidemias
Eligibility Criteria
Inclusion Criteria:
- total cholesterol concentration ≥ 200 mg/dL and < 300 mg/dL, and or LDL-C concentration ≥ 130 mg/dL and < 180 mg/dL
- were willing to consume control or plant stanol ester smoothie drinks two bottles per day immediately after a meal for four weeks,
- reachable by phone
- willing to declare written informed consent
- agreed in accordance with data protective stipulations and readiness to participate in the trial and to adhere to the study conditions.
Exclusion Criteria:
- Pregnant women
- obese
- diabetic subjects or subjects with random plasma glucose concentration > 200 mg/dL
- hyperthyroidism, a history of metabolic, endocrine and kidney disorders
- acute or chronic severe diseases possibly interfering with the evaluation of the outcome of the clinical trial (such as AIDS, tumor diseases, malignant hypertension, cardiac insufficiency according to NYHA III-IV)
- taking lipid-lowering medication or other medications likely to affect lipid metabolism
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Experimental
Arm Label
Placebo smoothie
Plant stanol ester smoothie
Arm Description
Outcomes
Primary Outcome Measures
Change (proportional) in LDL-C from baseline up to 4-weeks after plant stanol ester smoothie drink consumption.
Secondary Outcome Measures
Full Information
NCT ID
NCT02316808
First Posted
December 10, 2014
Last Updated
December 19, 2014
Sponsor
Raisio Group
Collaborators
Indonesia University
1. Study Identification
Unique Protocol Identification Number
NCT02316808
Brief Title
Cholesterol-lowering Effects of Plant Stanol Ester
Study Type
Interventional
2. Study Status
Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
August 2011 (undefined)
Primary Completion Date
December 2011 (Actual)
Study Completion Date
December 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Raisio Group
Collaborators
Indonesia University
4. Oversight
5. Study Description
Brief Summary
Efficacy of plant stanols as esters on LDL-cholesterol reduction is well documented. LDL-cholesterol lowering efficacy of the ingredient administered in a smoothie is less well known.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
91 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Placebo smoothie
Arm Type
Placebo Comparator
Arm Title
Plant stanol ester smoothie
Arm Type
Experimental
Intervention Type
Dietary Supplement
Intervention Name(s)
Plant stanol ester
Intervention Description
Smoothie that contains plant stanol ester
Intervention Type
Dietary Supplement
Intervention Name(s)
placebo
Intervention Description
Smoothie that contains placebo
Primary Outcome Measure Information:
Title
Change (proportional) in LDL-C from baseline up to 4-weeks after plant stanol ester smoothie drink consumption.
Time Frame
4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
total cholesterol concentration ≥ 200 mg/dL and < 300 mg/dL, and or LDL-C concentration ≥ 130 mg/dL and < 180 mg/dL
were willing to consume control or plant stanol ester smoothie drinks two bottles per day immediately after a meal for four weeks,
reachable by phone
willing to declare written informed consent
agreed in accordance with data protective stipulations and readiness to participate in the trial and to adhere to the study conditions.
Exclusion Criteria:
Pregnant women
obese
diabetic subjects or subjects with random plasma glucose concentration > 200 mg/dL
hyperthyroidism, a history of metabolic, endocrine and kidney disorders
acute or chronic severe diseases possibly interfering with the evaluation of the outcome of the clinical trial (such as AIDS, tumor diseases, malignant hypertension, cardiac insufficiency according to NYHA III-IV)
taking lipid-lowering medication or other medications likely to affect lipid metabolism
12. IPD Sharing Statement
Citations:
PubMed Identifier
29535869
Citation
Lestiani L, Chandra DN, Laitinen K, Ambarwati FD, Kuusisto P, Lukito W. Double-Blind Randomized Placebo Controlled Trial Demonstrating Serum Cholesterol Lowering Efficacy of a Smoothie Drink with Added Plant Stanol Esters in an Indonesian Population. Cholesterol. 2018 Feb 4;2018:4857473. doi: 10.1155/2018/4857473. eCollection 2018.
Results Reference
derived
Learn more about this trial
Cholesterol-lowering Effects of Plant Stanol Ester
We'll reach out to this number within 24 hrs